Protease Tag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis

ProAxsis logo e1509787092785

Protease Tag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis WP_Developer May 20, 2022 Recent Posts Protease Tag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasisMay 20, 2022 ProAxsis’ Protease Tag® NE Immunoassay highlighted at BTS 2016May 20, 2022 ProAxsis to present at 2016 North […]

ProAxsis’ Protease Tag® NE Immunoassay highlighted at BTS 2016

btc stop

ProAxsis’ Protease Tag® NE Immunoassay highlighted at BTS 2016 WP_Developer May 20, 2022 Recent Posts ProAxsis’ Protease Tag® NE Immunoassay highlighted at BTS 2016May 20, 2022 ProAxsis to present at 2016 North American Cystic Fibrosis ConferenceMay 20, 2022 ProAxsis receives Royal visitMay 20, 2022 Have Any Questions? Lorem ipsum dolor sit amet consectetur adipiscing elit. […]

Patient Experience Better Health Wishes

research e1621208959587

Our experienced team can provide a number of services for both academic and pharmaceutical company researchers, and are able to offer sample analysis at our purpose-built laboratory for a range of proteases and other inflammatory biomarkers.

Equipping Researchers Lab In The Developing

test tubes in clinic pharmacy and medical research laboratory with male scientist using pipette e1621208937699

Proteases are a large grouping of biological molecules that play pivotal regulatory roles in most physiological processes required for life. Unregulated protease activity (which occurs when the normal control of their action is lost) can be a trigger of many important human diseases thereby making active proteases important.

ProAxsis signs global in-licensing agreement

virus e1621208944993

ProAxsis has developed a range of unique molecules, known as ProteaseTags®, which have the capacity to rapidly and selectively bind active proteases, including those which are biomarkers of diagnostic and prognostic value.

ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016

PR8

ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]